Company / Revenue
OptimizeRx Corp Revenue History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Revenue
$92.1M
FY2025
5-year range
$43.3M / $92.1M
FY2021-FY2025
Trend
+28.8%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Revenue has increased for 9 consecutive years, from $7M in FY2016 to $92M in FY2025.
Based on SEC 10-K filings.
$92M in FY2025 with a 5-year CAGR of +30.2%.
Improved from $62M to $92M over the past 2 years.
Revenue over time
Growth rates
- 3-Year CAGR
- +14.5%
- 5-Year CAGR
- +30.2%
- 10-Year CAGR
- -
Key checks
Key Insights
- OptimizeRx Corp's revenue has grown for 9 consecutive years.
- 5-year CAGR of +30.2%, indicating consistent growth.
- In FY2025, revenue increased 28.8% year-over-year.
- Lowest revenue in the period was in FY2016.
Company context
Key Data Points
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | RevenueValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $92.1M | +28.8% |
| FY2024 | $71.5M | +14.5% |
| FY2023 | $62.5M | +1.9% |
| FY2022 | $61.3M | +41.5% |
| FY2021 | $43.3M | +76.1% |
| FY2020 | $24.6M | +16.0% |
| FY2019 | $21.2M | +74.9% |
| FY2018 | $12.1M | +56.5% |
| FY2017 | $7.8M | +7.4% |
| FY2016 | $7.2M | +11.0% |
As of FY2025 · SEC 10-K · Updated Jun 28, 2026